Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis

Journal of Hepatology

Volumn 62, Issue S1, 2015, Pages S131-S143

  Arroyo, Vicente ^a   Moreau, Richard ^b   Jalan, Rajiv ^c   Ginès, Pere ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acute decompensation of cirrhosis; Acute on chronic liver failure; Artificial liver support systems; Danger damage associated molecular patterns (DAMPs); Organ failure; Pathogen associated molecular patterns (PAMPs); Plasma exchange; Systemic inflammation

Indexed keywords

ACUTE ON CHRONIC LIVER FAILURE; ALCOHOLISM; ALGORITHM; BACTERIAL INFECTION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS B; HEPATITIS B VIRUS; HOMEOSTASIS; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER SUPPORT; LIVER TRANSPLANTATION; METHODOLOGY; MORTALITY; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; REVIEW; SCORING SYSTEM; SURVIVAL; ACUTE-ON-CHRONIC LIVER FAILURE; CLASSIFICATION; COMPLICATION; PHYSIOLOGY;

TOLL LIKE RECEPTOR;

ACUTE-ON-CHRONIC LIVER FAILURE; HEPATITIS B; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; TOLL-LIKE RECEPTORS;

EID: 84938881384     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.045     Document Type: Review

References (69)

1. C. Toledo, J.M. Salmerón, A. Rimola, M. Navasa, V. Arroyo, J. Llach, and et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated by cefotaxime Hepatology 17 1993 257
2. A. Follo, J.M. Llovet, M. Navasa, R. Planas, X. Forns, A. Francitorra, and et al. Renal impairment following spontaneous bacterial peritonitis in cirrhosis. Incidence, clinical course, predictive factors and prognosis Hepatology 20 1994 1495 1501
3. V. Arroyo, P. Ginès, A.L. Gerbes, F.J. Dudley, P. Gentilini, G. Laffi, and et al. Definition and diagnostic criteria of refractory ascites and hepatorenal síndrome in cirrhosis Hepatology 23 1996 164 176
4. R. Jalan, and R. Williams Acute-on-Chronic liver failure: Pathophysiological basis and therapeutic options Blood Purif 20 2002 252 261
5. L.L. Kjaergard, J. Liu, B. Als-Nielsen, and C. Gluud Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review JAMA 289 2003 217 222
6. M.S. Khuroo, M.S. Khuroo, and K.L. Farahat Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-análysis Liver Transpl 2004 1099 1106
7. S.K. Sarin, A. Kumar, J.A. Almeida, Y.K. Chawla, S.T. Fan, H. Grag, and et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) Hepatol Int 3 2009 269 282
8. J.S. Bajaj Defining acute-on-chronic liver failure: will East and West ever meet? Gastroenterology 144 2013 1337 1339
9. R. Jalan, C. Yurdaydin, J.S. Bajaj, S.K. Acharya, V. Arroyo, H.C. Lin, and et al. Toward an improved definition of acute-on-chronic liver failure Gastroenterology 147 2014 4 10
10. R. Moreau, R. Jalan, P. Gines, M. Pavesi, P. Angeli, J. Córdoba, and et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1426 1437
11. T. Gustot, J. Fernandez, E. García, P. Ginès, R. Moreau, R. Jalan, and et al. Short-term (28-day) clinical course and transplant-free mortality in acute-on-chronic liver failure (ACLF): evidence for reversibility of ACLF (a study from the CANONIC database) J Hepatol 60 2014 S228
12. J.L. Vincent, R. Moreno, J. Takala, S. Willats, A. De Mendoca, H. Bruining, and et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
13. M. Wehler, J. Kokoska, U. Reulbach, E.G. Hahn, R. Strauss, and et al. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems Hepatology 34 2001 255 261
14. V. Das, P.Y. Boelle, A. Galbois, and et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival Crit Care Med 38 2010 2108 2116
15. E. Levesque, E. Hoti, D. Azoulay, B. Guidet, E. Maury, R. Carbonell, and et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit J Hepatol 56 2012 Jan 95 102
16. D.C. Agnus, and T. van der Poll Severe sepsis and septic shock N Engl J Med 369 2013 840 851
17. R. Jalan, F. Saliba, M. Pavesi, A. Amorós, R. Moreau, P. Ginès, and et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure J Hepatol 61 2014 1038 1047
18. H. Li, M. Pavesi, B. Zeng, L.Y. Chen, S.T. Li, D.K. Qiu, and et al. "Eastern" type of acute-on-chronic liver failure (ACLF) is similar in pathophysiologic, diagnostic and prognostic criteria to the "Western" type: A comparison of Chinese hospitalized patients with hepatitis B with CANONIC data (abstract) Hepatology 60 2014 480A 481A
19. R. Medzhitov, D.S. Schneider, and M.P. Soares Disease tolerance as a defense strategy Science 335 2012 936 941
20. T. Gustot, F. Durand, D. Lebrec, J.L. Vincent, and R. Moreau Severe sepsis in cirrhosis Hepatology 50 2009 2022 2033
21. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
22. S.L. Foster, D.C. Hargreaves, and R. Medzhitov Gene-specific control of inflammation by TLR-induced chromatin modifications Nature 447 2007 972 978
23. S. Gandoura, E. Weiss, P.E. Rautou, M. Fasseu, T. Gustot, F. Lemoine, and et al. Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis J Hepatol 58 2013 936 948
24. J.D. MacMicking, C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, and et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 81 1995 641 650
25. J.A. Russell Management of sepsis N Engl J Med 355 2006 1699 1713
26. R.S. Hotchkiss, G. Monneret, and D. Payen Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy Nat Rev Immunol 13 2013 862 874
27. B. Byl, I. Roucloux, A. Crusiaux, E. Dupont, and J. Devière Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients Gastroenterology 104 1993 1492 1497
28. R. Moreau, E. Barrière, K.A. Tazi, B. Lardeux, D. Dargère, W. Urbanowicz, and et al. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis Hepatology 36 2002 1070 1078
29. K.A. Tazi, I. Bièche, V. Paradis, C. Guichard, I. Laurendeau, D. Dargère, and et al. In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats J Hepatol 46 2007 1075 1088
30. D. Thabut, K.A. Tazi, D. Bonnefont-Rousselot, M. Aller, O. Farges, M.C. Guimont, and et al. HDL administration attenuates liver proinflammatory response, restores liver eNOS activity and lowers portal pressure in cirrhotic rats Hepatology 46 2007 1893 1906
31. J. Devière, J. Content, C. Denys, P. Vandenbussche, L. Schandene, J. Wybran, and et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis Hepatology 11 1990 628 634
32. O. Le Moine, A. Marchant, D. De Groote, C. Azar, M. Goldman, and J. Devière Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis Hepatology 22 1995 1436 1439
33. K.A. Tazi, J.J. Quioc, V. Saada, A. Bezeaud, D. Lebrec, and R. Moreau Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M J Hepatol 45 2006 280 289
34. K.A. Tazi, J.J. Quioc, W. Abdel-Razek, Z. Tellier, C. Guichard, E. Ogier-Denis, and et al. Protein array technology to investigate cytokine production by monocytes from patients with advanced alcoholic cirrhosis: an ex vivo pilot study Hepatol Res 39 2009 706 715
35. A. Galbois, D. Thabut, K.A. Tazi, M. Rudler, M.S. Mohammadi, D. Bonnefont-Rousselot, and et al. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis Hepatology 49 2009 175 184
36. N. Coant, M. Simon-Rudler, T. Gustot, M. Fasseu, S. Gandoura, K. Ragot, and et al. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis J Hepatol 55 2011 784 793
37. M. Navasa, A. Follo, X. Filella, W. Jiménez, A. Francitorra, R. Planas, and et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality Hepatology 27 1998 1227 1232
38. H.E. Wasmuth, D. Kunz, E. Yagmur, A. Timmer-Stranghöner, D. Vidacek, E. Siewert, and et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 2005 195 201
39. R. Jalan, J. Fernandez, R. Wiest, B. Schnabl, R. Moreau, P. Angeli, and et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013 J Hepatol 60 2014 1310 1324
40. M.R. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
41. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
42. R. Jalan, P. Gines, J.C. Olson, R.P. Mookerjee, R. Moreau, G. García-Tsao, and et al. Acute-on chronic liver failure J Hepatol 57 2012 1336 1348
43. M. Schepke, F. Roth, R. Fimmers, K.A. Brensing, T. Sudhop, H.H. Schild, and et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting Am J Gastroenterol 98 2003 1167 1174
44. E. Cholongitas, L. Marelli, V. Shusang, M. Senzolo, K. Rolles, D. Patch, and et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation Liver Transpl 12 2006 1049 1061
45. J.S. Bajaj, J.G. O'Leary, K.R. Reddy, F. Wong, S.W. Biggins, H. Patton, and et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures Hepatology 60 2014 250 256
46. E. Theocharidou, G. Pieri, A.O. Mohammad, M. Cheung, E. Cholongitas, B. Agarwal, and et al. The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score Am J Gastroenterol 109 2014 554 562 10.1038/ajg.2013.466
47. P.S. Kamath, and W.R. Kim The model for end-stage liver disease (MELD) Hepatology 45 2007 797 805
48. W.R. Kim, S.W. Biggins, W.K. Kremers, R.H. Wiesner, P.S. Kamath, J.T. Benson, and et al. Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026
49. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
50. Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-Fischer P, et al. The CLIF Consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalized cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015;62:831-840.
51. P. Ginès, J. Fernández, F. Durand, and F. Saliba Management of critically-ill cirrhotic patients J Hepatol 56 2012 S13 S24
52. R. Bahirwani, O. Shaked, M. Bewtra, K. Forde, and K.R. Reddy Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes Transplantation 92 2011 952 957
53. B.W. Duan, S.C. Lu, M.L. Wang, J.N. Liu, P. Chi, W. Lai, and et al. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases J Surg Res 183 2013 936 943
54. A. Finkenstedt, K. Nachbaur, H. Zoller, M. Joannidis, J. Pratschke, I.W. Graziadei, and et al. Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list Liver Transpl 19 2013 879 886
55. T.I. Hassanein, R.R. Schade, and I.S. Hepburn Acute-on-chronic liver failure: extracorporeal liver assist devices Curr Opin Crit Care 17 2011 195 203
56. A. Vaid, H. Chweich, E.M. Balk, and B.L. Jaber Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis ASAIO J 58 2012 51 59
57. X. Xu, X. Liu, Q. Ling, Q. Wei, Z. Liu, X. Xu, and et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure PLoS One 8 2013 e58738
58. R. Bañares, F. Nevens, F.S. Larsen, R. Jalan, A. Albillos, M. Dollinger, and et al. RELIEF study group. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial Hepatology 57 2013 1153 1162
59. A. Kribben, G. Gerken, S. Haag, S. Herget-Rosenthal, U. Treichel, C. Betz, and et al. HELIOS Study Group. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure Gastroenterology 142 2012 782 789
60. F.S. Larsen, L.E. Schmidt, J. Wendon, and et al. Liver assisting with high volume plasma exchange in patients with acute liver failure Hepatology 52 2010 88A
61. V. Garg, H. Garg, A. Khan, N. Trehanpati, A. Kumar, B.C. Sharma, and et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure Gastroenterology 142 2012 505 512
62. X.Z. Duan, F.F. Liu, J.J. Tong, H.Z. Yang, J. Chen, X.Y. Liu, and et al. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure World J Gastroenterol 19 2013 1104 1110
63. A. Khanam, N. Trehanpati, V. Garg, C. Kumar, H. Garg, B.C. Sharma, and et al. Altered frequencies of dendritic cells and IFN-c-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure Liver Int 34 2014 505 513
64. M. Shi, Z. Zhang, R. Xu, H. Lin, J. Fu, Z. Zou, and et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients Stem Cells Transl Med 1 2012 725 731
65. S.F. Yuan, T. Jiang, L.H. Sun, R.J. Zheng, G.Q. Cao, N.Z. Ahat, and et al. Use of bone mesenchymal stem cells to treat rats with acute liver failure Genet Mol Res 30 2014 6962 6980
66. F.E. Tögel, and C. Westenfelder Mesenchymal stem cells: a new therapeutic tool for AKI Nat Rev Nephrol 6 2010 179 183
67. R.C. Huebert, and J. Rakela Cellular therapy for liver disease Mayo Clin Proc 89 2014 414 424
68. F. Wang, L. Zhou, X. Ma, W. Ma, C. Wang, Y. Lu, and et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study Transplant Proc 46 2014 192 198
69. Y. Zhang, X.M. Chen, and D.L. Sun Effects of coencapsulation of hepatocytes with adipose-derived stem cells in the treatment of rats with acute-on-chronic liver failure Int J Artif Organs 37 2014 133 141